在线客服: 点击这里给我发消息  新用户使用步骤:会员注册→充值→重新登入→进入资源
标题:Radium-223 and concomitant therapies in patients with metastatic castration-resistant prostate cancer: an international, early access, open-label, single-arm phase 3b trial.
时间:2019-08-14 21:30:36
DOI:10.1016/S1470-2045(16)30173-5
PMID:27473888
作者:Saad F;Carles J;Gillessen S;Heidenreich A;Heinrich D
出版源: 《Lancet Oncology》 ,2016 ,17 (9) :1306-1316
摘要:Radium-223 and concomitant therapies in patients with metastatic castration-resistant prostate cancer: an international, early access, open-label, single-arm phase 3b trialIn the previously reported ALSYMPCA trial in patients with castration-resistant prostate cancer and symptomatic bone metastases, overall survival was significantly longer in patients treated with radium-223 ...
大小:691 kb
页数:12 PAGES
下载: 点击下载
预览:

浏览器不支持嵌入PDF阅读,打开新页面在线阅读

目录:
  • Radium-223 and concomitant therapies in patients with metastatic castration-resistant prostate cancer: an international, early access, open-label, single-arm phase 3b trial
    • Introduction
    • Methods
      • Study design and patients
      • Procedures
      • Outcomes
      • Statistical analyses
      • Role of the funding source
    • Results
    • Discussion
    • Acknowledgments
    • References

本页内容由网络收集而来,版权归原创者所有,如有侵权请及时联系